Oxycodone/Naloxone vs. Oxycodone prolonged-release in moderate to severe chronic cancer pain: A propensity analysis comparison

被引：0
|
作者：
Corli, O. [1 ]
Lazzari, M. [2 ]
Marcassa, C. [3 ]
机构：
[1] IRCCS Mario Negri Pharmachol Res Inst, Oncol, Milan, Italy
[2] Univ Roma Tor Vergata, Emergency Care Pain Med & Anaesthesiol Dept, Rome, Italy
[3] Salvatore Maugeri Fdn, Cardiol Rehabil, Veruno Novara, Italy
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)30605-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1515
引用
收藏
页码：S209 / S209
页数：1
相关论文
共 50 条
  • [21] Prolonged-Release Oxycodone/Naloxone Improves Anal Sphincter Relaxation Compared to Oxycodone Plus Macrogol 3350
    Jakob Lykke Poulsen
    Christina Brock
    Debbie Grønlund
    Donghua Liao
    Hans Gregersen
    Klaus Krogh
    Asbjørn Mohr Drewes
    [J]. Digestive Diseases and Sciences, 2017, 62 : 3156 - 3166
  • [22] Prolonged-release oxycodone/naloxone in the treatment of neuropathic pain - results from a large observational study
    Hermanns, Kai
    Junker, Uwe
    Nolte, Thomas
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2012, 13 (03) : 299 - 311
  • [23] Prolonged-Release Oxycodone/Naloxone in Nonmalignant Pain: Single-Center Study in Patients with Constipation
    Gatti, Antonio
    Casali, Manuela
    Lazzari, Marzia
    Tufaro, Giuseppe
    Gafforio, Paolo
    Silvestri, Claudia
    Marcassa, Claudio
    Sabato, Alessandro F.
    [J]. ADVANCES IN THERAPY, 2013, 30 (01) : 41 - 59
  • [24] Safety and efficacy of oxycodone/naloxone vs. oxycodone vs. morphine for the treatment of chronic low back pain: results of a 12 week prospective, randomized, open-label blinded endpoint streamlined study with prolonged-release preparations
    Ueberall, Michael A.
    Mueller-Schwefe, Gerhard H. H.
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2015, 31 (07) : 1413 - 1429
  • [25] Prolonged-Release Oxycodone/Naloxone in Nonmalignant Pain: Single-Center Study in Patients with Constipation
    Antonio Gatti
    Manuela Casali
    Marzia Lazzari
    Giuseppe Tufaro
    Paolo Gafforio
    Claudia Silvestri
    Claudio Marcassa
    Alessandro F. Sabato
    [J]. Advances in Therapy, 2013, 30 : 41 - 59
  • [26] Efficacy and safety of oral Morphine versus oral Prolonged-Release Oxycodone/Naloxone in opioid-naive cancer patients: a propensity analysis
    Greco, M. T.
    Roberto, A.
    Legramandi, L.
    Galli, F.
    Corli, O.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [27] Patient assessment of the efficacy and tolerability of coadministered prolonged release oral oxycodone and naloxone in severe chronic pain
    Nadstawek, J.
    Leyendecker, P.
    Hopp, M.
    Ruckes, C.
    Fleischer, W.
    Reimer, K.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 543 - 543
  • [28] Long-term evaluation of combined prolonged-release oxycodone and naloxone in patients with moderate-to-severe chronic pain: pooled analysis of extension phases of two Phase III trials
    Blagden, M.
    Hafer, J.
    Duerr, H.
    Hopp, M.
    Bosse, B.
    [J]. NEUROGASTROENTEROLOGY AND MOTILITY, 2014, 26 (12): : 1792 - 1801
  • [29] Colorectal Transit and Volume During Treatment With Prolonged-release Oxycodone/Naloxone Versus Oxycodone Plus Macrogol 3350
    Poulsen, Jakob L.
    Mark, Esben B.
    Brock, Christina
    Frokjaer, Jens B.
    Krogh, Klaus
    Drewes, Asbjorn M.
    [J]. JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2018, 24 (01) : 119 - 127
  • [30] Efficacy and tolerability of low-dose oral prolonged-release oxycodone/naloxone for chronic nononcological pain in older patients
    Guerriero, Fabio
    Sgarlata, Carmelo
    Marcassa, Claudio
    Ricevuti, Giovanni
    Rollone, Marco
    [J]. CLINICAL INTERVENTIONS IN AGING, 2015, 10 : 1 - 11
12345